pgh1 modulates sensitivity resistance multiple antimalarials plasmodium falciparum 
throughout latter half century development spread resistance front-line antimalarial compounds used prevention treatment severe form human malaria given cause grave clinical concern polymorphisms pfmdr1 gene encoding p-glycoprotein homologue pgh1 protein plasmodium falciparum linked chloroquine resistance pgh1 also implicated resistance mefloquine halofantrine- however conclusive evidence direct causal association pfmdr1 resistance antimalarials remained elusive single genetic cross suggested pgh1 involved resistance chloroquine mefloquine provide direct proof mutations pgh1 can confer resistance mefloquine quinine halofantrine mutations influence parasite resistance towards chloroquine strain-specific manner level sensitivity structurally unrelated compound artemisinin important implications development efficacy future antimalarial agents 
